Alexandria reports third quarter financial results
The company reported a diluted net loss per share of $3.74 and FFO per share of $1.54 for Q3 2026.
See the latest news and media coverage for Alexandria. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life science–focused real estate investment trust
are.comLast updated
In short: Alexandria posted a Q3 loss, sold assets, and extended a $5B credit line.
The company reported a diluted net loss per share of $3.74 and FFO per share of $1.54 for Q3 2026.
The deal reduces borrowing margins to SOFR plus 72.5 basis points. This strengthens liquidity and long-term financial flexibility for the REIT.
The company will release third quarter operating and financial results after market close on Monday, October 26, 2026.
The notes bear a 7.250% interest rate through 2032, with proceeds allocated for working capital and debt reduction.
KKR will hold a 49 percent non-controlling equity interest and a 28.5 percent indirect ownership interest in the research center.
Some items in its portfolio are in contract to sell, such as 421 Park Drive of the Alexandria Center for Life Science campus in Boston.
Alexandria Real Estate Equities dropped 8.55% to $41.62 after BMO Capital Markets downgraded the life sciences property owner to a Sell-equivalent rating and lowered its...
BMO Capital cut its Alexandria Real Estate target to USD 41.00 from USD 48.00 on October 12, 2026. Alexandria Real Estate is scheduled to report...
Track Alexandria and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Alexandria and other trending companies.